loadpatents
name:-0.035924911499023
name:-0.030474901199341
name:-0.00047802925109863
Tinti; Maria Ornella Patent Filings

Tinti; Maria Ornella

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tinti; Maria Ornella.The latest application filed is for "stereoselective process and crystalline forms of a camptothecin".

Company Profile
0.26.34
  • Tinti; Maria Ornella - Rome IT
  • Tinti; Maria Ornella - Pomezia IT
  • Tinti; Maria Ornella - Roma IT
  • Tinti; Maria Ornella - Pomezia Rome
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Stereoselective process and crystalline forms of a camptothecin
Grant 8,124,769 - Carminati , et al. February 28, 2
2012-02-28
Stereoselective process and crystalline forms of a camptothecin
Grant 8,101,758 - Carminati , et al. January 24, 2
2012-01-24
Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride
Grant 7,858,820 - Tinti December 28, 2
2010-12-28
Stereoselective Process And Crystalline Forms Of A Camptothecin
App 20100311784 - Carminati; Paolo ;   et al.
2010-12-09
Stereoselective Process And Crystalline Forms Of A Camptothecin
App 20100311783 - Carminati; Paolo ;   et al.
2010-12-09
Stereoselective process and crystalline forms of a camptothecin
Grant 7,799,921 - Carminati , et al. September 21, 2
2010-09-21
Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity
Grant 7,713,956 - Carminati , et al. May 11, 2
2010-05-11
Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
Grant 7,705,012 - Pisano , et al. April 27, 2
2010-04-27
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
Grant RE41,226 - Giannessi , et al. April 13, 2
2010-04-13
Derivatives Of 4-trimethylammonium-3-aminobutyrate And 4-trimethylphosphonium-3-aminobutyrate As Cpt-inhibitors
App 20090312286 - Giannessi; Fabio ;   et al.
2009-12-17
Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
Grant 7,629,003 - Pisano , et al. December 8, 2
2009-12-08
7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups
Grant 7,612,081 - Giannini , et al. November 3, 2
2009-11-03
Stereoselective Process And Crystalline Forms Of A Camptothecin
App 20090239893 - Carminati; Paolo ;   et al.
2009-09-24
7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
Grant 7,589,099 - Pisano , et al. September 15, 2
2009-09-15
Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
Grant 7,585,519 - Pisano , et al. September 8, 2
2009-09-08
Fluorocombretastatin and derivatives thereof
Grant 7,572,778 - Giannini , et al. August 11, 2
2009-08-11
Esters in position 20 of camptothecins
Grant 7,498,340 - Marzi , et al. March 3, 2
2009-03-03
Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
App 20080293812 - Gallo; Maria Grazia ;   et al.
2008-11-27
Esters in position 20 of camptothecins
Grant 7,452,900 - Marzi , et al. November 18, 2
2008-11-18
Derivatives of Aminobutanoic Acid Inhibiting Cpt
App 20080161395 - Giannessi; Fabio ;   et al.
2008-07-03
Use of .alpha.-phenylthiocarboxylic and .alpha.-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
Grant 7,375,124 - Giannessi , et al. May 20, 2
2008-05-20
Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
Grant 7,368,605 - Giannessi , et al. May 6, 2
2008-05-06
Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation
App 20080027098 - Giannessi; Fabio ;   et al.
2008-01-31
Dealkylated Derivatives of Pyrrolo[2,1-B]Benzothiazepines with Atypical Antipsy-Chotic Activity
App 20070270402 - Carminati; Paolo ;   et al.
2007-11-22
Camptothecin Derivatives Conjugated in Position 20 with Integrin Antagonists
App 20070232639 - Pisano; Claudio ;   et al.
2007-10-04
Camptothecins with a modified lactone ring
Grant 7,273,873 - Marzi , et al. September 25, 2
2007-09-25
Esters in position 20 of camptothecins
App 20070213353 - Marzi; Mauro ;   et al.
2007-09-13
Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
App 20070190128 - Pisano; Claudio ;   et al.
2007-08-16
Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity
Grant 7,169,808 - Fanto' , et al. January 30, 2
2007-01-30
Bis-heterocyclic compounds with antitumour and chemosensitising activity
App 20060211759 - Giannini; Giuseppe ;   et al.
2006-09-21
Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
App 20060205967 - Gallo; Maria Grazia ;   et al.
2006-09-14
Bis-heterocyclic compounds with antitumour and chemosensitising activity
Grant 7,084,166 - Giannini , et al. August 1, 2
2006-08-01
Fluorocombretastatin and derivatives thereof
App 20060160778 - Giannini; Giuseppe ;   et al.
2006-07-20
Use of alpha-phenylthiocarboxylic and alpha-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
App 20060154979 - Giannessi; Fabio ;   et al.
2006-07-13
Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
App 20060069100 - Giannessi; Fabio ;   et al.
2006-03-30
Esters in position 20 of camptothecins
App 20050256148 - Marzi, Mauro ;   et al.
2005-11-17
Camptothecins with a modified lactone ring
App 20050154003 - Marzi, Mauro ;   et al.
2005-07-14
Tricyclic derivatives of indole with antiangiogenic activity
App 20050124647 - Giannini, Gisuseppe ;   et al.
2005-06-09
Tricyclic derivatives of indole with antiangiogenic activity
Grant 6,887,892 - Giannini , et al. May 3, 2
2005-05-03
Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
App 20050079209 - Pisano, Claudio ;   et al.
2005-04-14
Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid
Grant 6,822,115 - Giannessi , et al. November 23, 2
2004-11-23
Esters of I-carnitine or alkanoyl I-carnitines
Grant 6,797,281 - Pisano , et al. September 28, 2
2004-09-28
Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
App 20040186175 - Pisano, Claudio ;   et al.
2004-09-23
Bis-heterocyclic compounds with antitumour and chemosensitising activity
App 20040053987 - Giannini, Giuseppe ;   et al.
2004-03-18
Tricyclic derivatives of indole with antiangiogenic activity
App 20040034052 - Giannini, Gisuseppe. ;   et al.
2004-02-19
Use of pamoic acid or one of its derivatives, or one of its analogues , for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
App 20040029963 - Gallo, Maria Grazia ;   et al.
2004-02-12
Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
App 20040024061 - Tinti, Maria Ornella
2004-02-05
Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity
App 20030195257 - Fanto, Nicola ;   et al.
2003-10-16
Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino- -butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid
App 20030153783 - Giannessi, Fabio ;   et al.
2003-08-14
Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino- -butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid
App 20030153784 - Giannessi, Fabio ;   et al.
2003-08-14
Industrial process for the production of L-carnitine
Grant 6,566,552 - Tinti , et al. May 20, 2
2003-05-20
Industrial process for the production of L-carnitine
App 20020165408 - Tinti, Maria Ornella ;   et al.
2002-11-07
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
Grant 6,444,701 - Giannessi , et al. September 3, 2
2002-09-03
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
App 20020052348 - Giannessi, Fabio ;   et al.
2002-05-02
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
Grant 6,369,073 - Giannessi , et al. April 9, 2
2002-04-09
Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
Grant 6,337,349 - Scafetta , et al. January 8, 2
2002-01-08
Process for the preparation of R-(-)-carnitine
App 20010031892 - Giannessi, Fabio ;   et al.
2001-10-18
Solid Compositions Suitable For Oral Administration Comprising An Alkanoyl-l-carnitine Magnesium Citrate
App 20010027214 - SCAFETTA, NAZARENO ;   et al.
2001-10-04
Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and alkanoyl L-carnitines
App 20010009923 - Santaniello, Mose ;   et al.
2001-07-26
Chemical process for the stereoselective synthesis of R-(-)- carnitine
App 20010003135 - Marzi, Mauro ;   et al.
2001-06-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed